Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2025

ESMO Colloquium supported by Novartis - Radiotheranostics in oncology: Optimising the science, building capacity and streamlining the regulation

Current policy and regulatory hurdles for RLT implementation: Regulatory approval, centre accreditation and radioprotection, reimbursement

Date

04 Mar 2025

Session

ESMO Colloquium supported by Novartis - Radiotheranostics in oncology: Optimising the science, building capacity and streamlining the regulation

Topics

Radiation Oncology

Tumour Site

Presenters

Valentina Di Iorio

Authors

V. Di Iorio

Author affiliations

  • IRST - Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRCCS S.r.l., 47014 - Meldola/IT

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Welcome and introduction

Presenter: Alessandra Gennari

Session: ESMO Colloquium supported by Novartis - Radiotheranostics in oncology: Optimising the science, building capacity and streamlining the regulation

Resources:

Slides

Webcast

Q&A and discussion

Session: ESMO Colloquium supported by Novartis - Radiotheranostics in oncology: Optimising the science, building capacity and streamlining the regulation

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.